Corazon Hobbs-Oshiro
Internal Medicine · Waipahu, HINPI 1306830476
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 287 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 14.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $5,943 and has fallen 99.6% since, to $22 in 2024. Among internal medicine clinicians in HI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 287 payments — averaging $27.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Amarin Pharma, Inc.$884
- Boehringer Ingelheim$668
- Johnson & Johnson$599
- AbbVie$583
- Lilly USA, LLC$566
- plus $3K from 18 others
What the payments were for
- Food & beverage$7,943100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 33 | $1,180 |
| Amarin Pharma, Inc. | 21 | $884 |
| Boehringer Ingelheim | 18 | $668 |
| Johnson & Johnson | 17 | $599 |
| AbbVie(2 entities) | 17 | $583 |
| Lilly USA, LLC | 21 | $566 |
| Sanofi-aventis U.S. LLC | 18 | $549 |
| Pfizer | 13 | $532 |
| Insmed, Inc. | 22 | $494 |
| Amgen(2 entities) | 11 | $429 |
| Novo Nordisk | 28 | $428 |
| Arbor Pharmaceuticals, Inc. | 28 | $306 |
| GSK | 19 | $204 |
| Genentech USA, Inc. | 1 | $125 |
| Regeneron Healthcare Solutions, Inc. | 1 | $111 |
| Kowa Pharmaceuticals America, Inc. | 6 | $80 |
| Merck | 4 | $67 |
| Novartis | 2 | $43 |
| Ironwood Pharmaceuticals, Inc | 2 | $31 |
| Radius Health, Inc. | 1 | $22 |
| Astellas Pharma US Inc | 1 | $17 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
| Dermira, Inc. | 1 | $12 |
| Gilead | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,955 in reported general payments places this provider in the 90th percentile of 655 internal medicine providers in Hawaii.
Other internal medicine in Waipahu
- Charlie SonidoWaipahu$34K
- Rosalo PaesteWaipahu$22K
- Nenita Bala-AlbanoWaipahu$11K
- Scott StromattKamuela$385K
- Keith WooHonolulu$106K
- Ronald PerryHonolulu$102K
- Laurie TomHonolulu$95K
- Yusuke MiyataniHonolulu$80K
- Joshua TanHonolulu$76K
- Jose de LeonHonolulu$52K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.